Shimin Wu
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing 2
-
- Biosensors and Analytical Detection 2
-
- Glycogen Storage Diseases and Myoclonus 2
-
- Lipid metabolism and disorders 2
-
- Caveolin-1 and cellular processes 2
-
- Lung Cancer Treatments and Mutations 2
-
- Liver Disease Diagnosis and Treatment 2
-
- Adipose Tissue and Metabolism 2
- Co-authors
- Xiaoping LuoYulong ZhangDaming WangLi LiMin ChenJieli ZhangXinhui ZhengYuguo Tang
- Partner nations
- ChinaUnited StatesGreece
In The Last Decade
Shimin Wu
25 papers receiving 560 citations
Peers
Comparison fields: 5 of 97
- Infectious Diseases 142
- Biomedical Engineering 204
- Molecular Biology 263
- Rheumatology 54
- Behavioral Neuroscience 11
Countries citing papers authored by Shimin Wu
This map shows the geographic impact of Shimin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimin Wu more than expected).
Fields of papers citing papers by Shimin Wu
This network shows the impact of papers produced by Shimin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimin Wu. The network helps show where Shimin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shimin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 6 | |
| 10 | 2020 | 251 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 2 | |
| 15 | 2017 | 16 | |
| 16 | 2016 | 13 | |
| 17 | 2011 | 27 | |
| 18 | 2011 | 63 | |
| 19 | 2009 | 3 | |
| 20 | [Study on Growth and Maturation of Megakaryocyte Progenitors In Vitro in Patients with Chronic Idiopathic Thrombocytopenic Purpura] | 2001 | 1 |
About Shimin Wu
Shimin Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Rheumatology, having authored 26 papers that have together received 564 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (2 papers), Biosensors and Analytical Detection (2 papers), Caveolin-1 and cellular processes (2 papers), Lung Cancer Treatments and Mutations (2 papers), Glycogen Storage Diseases and Myoclonus (2 papers), Liver Disease Diagnosis and Treatment (2 papers), SARS-CoV-2 detection and testing (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Infectious Diseases (142 citations), Biomedical Engineering (204 citations) and Molecular Biology (263 citations). Shimin Wu has collaborated with scholars based in China, United States and Greece. Frequent co-authors include Xiaoping Luo, Yulong Zhang, Daming Wang, Li Li, Min Chen, Jieli Zhang, Xinhui Zheng, Yuguo Tang, Shiguo Liu and Xiaohui Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.